Policy | Funding | Influence
Insights for changemakers on navigating government opportunities.
G2G Bioscience Bulletin – January 23, 2026
G2G Founder & CEO Liz Powell was in Birmingham, AL in her capacity as a leader of Women’s Health Advocates, to convene an event that brought together elected officials, medical professionals, doulas, community advocates and educators to examine the policies and systems shaping maternal health outcomes.
G2G Bioscience Bulletin – January 17, 2026
G2G Founder & CEO Liz Powell was at JP Morgan where she engaged with innovators, leaders and investors from across the healthcare and the life sciences sectors. Notably, Liz with other women’s health leaders presented the release of the Follow the Exits: Why Women’s Health Is a Smart Bet in Healthcare report.
G2G Bioscience Bulletin – January 12, 2026
G2G is co-leading a five-part webinar series on Navigating Government Systems for MedTech from January 27 to February 24
G2G Bioscience Bulletin – December 22, 2025
G2G was on Capitol Hill this week and met with Senate Health Education Labor & Pensions (HELP) Committee Chair Bill Cassidy (R-LA), and the offices of House Speaker Mike Johnson (R-LA) and Energy & Commerce Health Subcommittee Chair Morgan Griffith (R-VA) to advocate for the National Plan for Epilepsy Act.
Bioscience Bulletin – December 12, 2025
G2G was on Capitol Hill this week and met with Senate Health Education Labor & Pensions (HELP) Committee Chair Bill Cassidy (R-LA), and the offices of House Speaker Mike Johnson (R-LA) and Energy & Commerce Health Subcommittee Chair Morgan Griffith (R-VA) to advocate for the National Plan for Epilepsy Act.
Bioscience Bulletin – December 5, 2025
Federal Legislative Updates Ohio Legislative Updates G2G Blog Back to All Posts G2G Highlights G2G was on Capitol Hill on Monday and Tuesday with Women’s Health Advocates (WHA) and the Breast Cancer Early…
Bioscience Bulletin – Nov 21, 2025
G2G had the privilege to be participant and organizing partner at Friday’s Empowering the Future of Biotechnology Through Trusted Science event hosted by ATCC.
Bioscience Bulletin – Nov 14, 2025
On Monday, G2G Founder & CEO, Liz Powell was among the women’s health leaders at the Department of Health & Human Services (HHS) where Secretary Kennedy and FDA Director Marty Makary, announced that hormone replacement therapy (HRT) products for perimenopause and menopause would no longer need to carry black box warnings.
Bioscience Bulletin – Nov 9, 2025
Last week was an active week for health policy! Our Founder and CEO, Liz Powell, Esq., MPH attended the Milken Institute Future of Health Summit, in Washington, D.C.. She participated in the
